Supramolecular cancer photoimmunotherapy based on precise peptide self-assembly design
Y Liu, L Zhang, R Chang, X Yan - Chemical Communications, 2022 - pubs.rsc.org
Combinational photoimmunotherapy (PIT) is considered to be an ideal strategy for the
treatment of highly recurrent and metastatic cancer, because it can ablate the primary tumor …
treatment of highly recurrent and metastatic cancer, because it can ablate the primary tumor …
[HTML][HTML] Near infrared photoimmunotherapy: a review of recent progress and their target molecules for cancer therapy
TM Mohiuddin, C Zhang, W Sheng, M Al-Rawe… - International journal of …, 2023 - mdpi.com
Near infrared photoimmunotherapy (NIR-PIT) is a newly developed molecular targeted
cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces …
cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces …
[HTML][HTML] EGFR-targeted photodynamic therapy
L Ulfo, PE Costantini, M Di Giosia, A Danielli… - Pharmaceutics, 2022 - mdpi.com
The epidermal growth factor receptor (EGFR) plays a pivotal role in the proliferation and
metastatization of cancer cells. Aberrancies in the expression and activation of EGFR are …
metastatization of cancer cells. Aberrancies in the expression and activation of EGFR are …
[HTML][HTML] Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C44Mab-34, for Multiple Applications against Oral Carcinomas
H Suzuki, K Ozawa, T Tanaka, MK Kaneko, Y Kato - Biomedicines, 2023 - mdpi.com
Cluster of differentiation 44 (CD44) has been investigated as a cancer stem cell (CSC)
marker as it plays critical roles in tumor malignant progression. The splicing variants are …
marker as it plays critical roles in tumor malignant progression. The splicing variants are …
Photodynamic Therapy for Bladder Cancers, A Focused Review†
Bladder cancer is the first cancer for which PDT was clinically approved in 1993.
Unfortunately, it was unsuccessful due to side effects like bladder contraction. Here, we …
Unfortunately, it was unsuccessful due to side effects like bladder contraction. Here, we …
Current status and future expectations of nanobodies in oncology trials
T De Pauw, L De Mey, JM Debacker… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Monoclonal antibodies have revolutionized personalized medicine for cancer in
recent decades. Despite their broad application in oncology, their large size and complexity …
recent decades. Despite their broad application in oncology, their large size and complexity …
[HTML][HTML] Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond
D Wei, J Qi, MR Hamblin, X Wen, X Jiang, H Yang - Theranostics, 2022 - ncbi.nlm.nih.gov
Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment
modality based on a target-specific photosensitizer conjugate (TSPC) composed of an NIR …
modality based on a target-specific photosensitizer conjugate (TSPC) composed of an NIR …
[HTML][HTML] Phototheranostics of splenic myeloid-derived suppressor cells and its impact on spleen metabolism in tumor-bearing mice
Simple Summary Myeloid-derived suppressor cells (MDSCs) create an immune suppressive
tumor microenvironment making them an important target in cancer. Here we demonstrated …
tumor microenvironment making them an important target in cancer. Here we demonstrated …
Near-infrared photoimmunotherapy and anti-cancer immunity
K Nakajima, M Ogawa - International Immunology, 2024 - academic.oup.com
The activation of the anti-cancer immune system is an important strategy to control cancer. A
new form of cancer phototherapy, near-infrared photoimmunotherapy (NIR-PIT), was …
new form of cancer phototherapy, near-infrared photoimmunotherapy (NIR-PIT), was …
[HTML][HTML] Combination of near-infrared photoimmunotherapy using trastuzumab and small protein mimetic for HER2-positive breast cancer
H Yamaguchi, J On, T Morita, T Suzuki… - International Journal of …, 2021 - mdpi.com
Near-infrared photoimmunotherapy (NIR-PIT) is a promising cancer therapy based on a
monoclonal antibody conjugated to a photosensitizer (IR700Dye) that is activated by near …
monoclonal antibody conjugated to a photosensitizer (IR700Dye) that is activated by near …